Return on Equity (ROE)
Higher than 28% of Healthcare sector peers
Updated 1078h ago
Sector Performance
28th percentileEXAS
-8.7%
Sector Median
11.0%
Sector Avg
31.7%
Deep Analysis
Exact Sciences Corporation (EXAS) has a Return on Equity (ROE) of -8.7% as of May 2026.
This places EXAS in the 28th percentile of the Healthcare sector, which has a median Return on Equity (ROE) of 11.0% and a sector average of 31.7%. EXAS's Return on Equity (ROE) is 179.1% below the sector median, a significant divergence that warrants closer examination. In context: ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about EXAS?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
How does EXAS's Return on Equity (ROE) compare to its sector?
EXAS's Return on Equity (ROE) of -8.7% compares to a Healthcare sector median of 11.0%, placing it in the 28th percentile.
Who are EXAS's closest peers by Return on Equity (ROE)?
The closest Healthcare peers by Return on Equity (ROE) include: BIIB (7.7%), BDX (6.6%), ZBH (6.1%), TECH (5.3%), RVTY (3.2%).
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master EXAS's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full EXAS research report →EXAS
-8.7%
Sector Median
11.0%
Sector Avg
31.7%
How EXAS's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.